长期丁丙诺啡治疗中断后急性照护、阿片处方与过量的关联
该回顾性队列分析利用MarketScan多州医疗补助索赔数据库(2013-2017),纳入连续接受丁丙诺啡≥180天的成人(18-64岁),按保留治疗6-9、9-12、12-15、15-18个月分组,比较停药后6个月内急性照护服务使用和过量风险。结果显示各队列不良结局均常见,保留15-18个月组较6-9个月组急诊就诊、住院和填写阿片处方的比值显著降低,但约5%患者发生至少一次医疗处理过的过量。
要点
- 停药后6个月内急诊就诊率高达42.1%-49.9%,急性照护使用普遍。
- 保留15-18个月组较6-9个月组急诊就诊OR=0.75(95%CI=0.65-0.86)。
- 各队列约5%患者经历至少一次医疗处理过的过量。
核心结论
- 丁丙诺啡停药后急性照护服务使用和过量风险高,与治疗持续时间无关。
- 治疗持续时间超过15个月后,结局显著优于6-9个月组,但主要不良结局发生率仍高。
研究设计与样本
- 样本为18-64岁连续接受丁丙诺啡≥180天的成人,按保留6-9、9-12、12-15、15-18个月分组。
- 结局评估要求停药后连续参保6个月,主要结局包括全因急诊就诊、全因住院、阿片处方和药物过量(阿片或非阿片)。
主要发现
- 各队列不良事件常见,42.1%-49.9%患者至少一次急诊就诊。
- 保留15-18个月组(N=931)较6-9个月组(N=4,126)停药后6个月内急诊就诊OR=0.75(95%CI=0.65-0.86)。
- 保留15-18个月组较6-9个月组住院OR=0.79(95%CI=0.64-0.99),填写阿片处方OR=0.67(95%CI=0.56-0.80)。
- 各队列约5%患者经历至少一次医疗处理过的过量。
关键数值与推荐
- 连续丁丙诺啡治疗≥180天为纳入标准,保留分组为6-9、9-12、12-15、15-18个月。
- 主要不良结局包括全因急诊就诊、全因住院、阿片处方和药物过量(阿片或非阿片)。
临床怎么用
- 临床应关注丁丙诺啡停药后6个月内的急性照护需求和过量风险。
- 延长丁丙诺啡治疗至15个月以上可能与停药后急性照护使用降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum. METHODS: A retrospective longitudinal cohort analysis was performed using the MarketScan multistate Medicaid claims database (2013-2017), covering 12 million beneficiaries annually. The sample included adults (18-64 years of age) who received buprenorphine continuously for ≥180 days by cohorts retained for 6-9 months, 9-12 months, 12-15 months, and 15-18 months. For outcome assessment in the postdiscontinuation period, patients had to be continuously enrolled in Medicaid for 6 months after buprenorphine discontinuation. Primary adverse outcomes included all-cause emergency department visits, all-cause inpatient hospitalizations, opioid prescriptions, and drug overdose (opioid or non-opioid). RESULTS: Adverse events were common across all cohorts, and almost half of patients (42.1%-49.9%) were seen in the emergency department at least once. Compared with patients retained on buprenorphine for 6-9 months (N=4,126), those retained for 15-18 months (N=931) had significantly lower odds of emergency department visits (odds ratio=0.75, 95% CI=0.65-0.86), inpatient hospitalizations (odds ratio=0.79, 95% CI=0.64-0.99), and filling opioid prescriptions (odds ratio=0.67, 95% CI=0.56-0.80) in the 6 months following discontinuation. Approximately 5% of patients across all cohorts experienced one or more medically treated overdoses. CONCLUSIONS: Risk of acute care service use and overdose were high following buprenorphine discontinuation irrespective of treatment duration. Superior outcomes became significant with treatment duration beyond 15 months, although rates of the primary adverse outcomes remained high.
引用
- Williams AR, Samples H, Crystal S, et al. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder. Am J Psychiatry. 2019. PMID: 31786933. doi:10.1176/appi.ajp.2019.19060612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。